Effects of the 5-HT4 receptor agonist, tegaserod, on in vitro human platelet aggregation

被引：0
|
作者：
Serebruany, V. L. [1 ]
El Mouelhi, M. [2 ]
Pfannkuche, H. [3 ]
Rose, K. [4 ]
Marro, M. [5 ]
Angiolillo, D. J. [6 ]
机构：
[1] HeartDrug Res Labs, Cardiol, Baltimore, MD USA
[2] Novartis Inst Biomed Res, Translat Med GI, E Hanover, NJ USA
[3] Novartis Pharma AG, Translat Med, Basel, Switzerland
[4] Novartis, Biomarker Dev, E Hanover, NJ USA
[5] Novartis, Translat Med, Horsham, W Sussex, England
[6] Univ Florida, Coll Med, Cardiol, Jacksonville, FL USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-022
引用
收藏
页码：631 / 631
页数：1
相关论文
共 50 条
  • [1] Investigations on 5-HT4 Receptor Expression and Effects of Tegaserod on Human Platelet Aggregation In Vitro
    Serebruany, Victor L.
    El Mouelhi, Mohamed
    Pfannkuche, Hans-Juergen
    Rose, Kristine
    Marro, Martin
    Angiolillo, Dominick J.
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (06) : 543 - 552
  • [2] Tegaserod - A new 5-HT4 agonist
    Lacy, BE
    Yu, SY
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 34 (01) : 27 - 33
  • [3] The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo
    Beattie, DT
    Smith, JAM
    Marquess, D
    Vickery, RG
    Armstrong, SR
    Pulido-Rios, T
    McCullough, JL
    Sandlund, C
    Richardson, C
    Mai, N
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 549 - 560
  • [4] Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses
    Delco, Michelle L.
    Nieto, Jorge E.
    Craigmill, Arthur L.
    Stanley, Scott D.
    Snyder, Jack R.
    VETERINARY THERAPEUTICS, 2007, 8 (01) : 77 - 87
  • [5] The effects of tegaserod, a 5-HT4 receptor agonist, on gastric emptying in a murine model of diabetes mellitus
    Crowell, MD
    Mathis, C
    Schettler, VA
    Yunus, T
    Lacy, BE
    NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (05): : 738 - 743
  • [6] Safety Profile of Tegaserod, a 5-HT4 Receptor Agonist, for the Treatment of Irritable Bowel Syndrome
    William L. Hasler
    Philip Schoenfeld
    Drug Safety, 2004, 27 : 619 - 631
  • [7] Safety profile of tegaserod, a 5-HT4 receptor agonist, for the treatment of irritable bowel syndrome
    Hasler, WL
    Schoenfeld, P
    DRUG SAFETY, 2004, 27 (09) : 619 - 631
  • [8] The 5-HT4 receptor agonist, tegaserod, stimulates electrolyte/water secretion in the rat colon
    Weber, E
    Bernhard, M
    Pfannkuche, HJ
    GASTROENTEROLOGY, 2004, 126 (04) : A147 - A147
  • [9] Clinical pharmacokinetics of tegaserod, a serotonin 5-HT4 receptor partial agonist with promotile activity
    Appel-Dingemanse, S
    CLINICAL PHARMACOKINETICS, 2002, 41 (13) : 1021 - 1042
  • [10] Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT4 Receptor Partial Agonist with Promotile Activity
    Silke Appel-Dingemanse
    Clinical Pharmacokinetics, 2002, 41 : 1021 - 1042
12345